Profilo
John K.
Cini was the founder of Sonnet BioTherapeutics Holdings, Inc., founded in 2011, where the title held was Chief Scientific Officer from 2020 to 2025.
Dr. Cini is the founder of Sonnet BioTherapeutics, Inc., founded in 2015, holding the title of Chief Scientific Officer starting in 2015.
Former jobs include Executive Director at Medarex, Inc. and Vice President-Discovery & Development Sciences at Outlook Therapeutics, Inc. from 2011 to 2015.
Education includes a doctorate from the University of North Texas.
Posizioni attive di John Cini
| Società | Posizione | Inizio |
|---|---|---|
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Fondatore | 01/01/2015 |
Precedenti posizioni note di John Cini
| Società | Posizione | Fine |
|---|---|---|
| SONNET BIOTHERAPEUTICS | Fondatore | 02/12/2025 |
| OUTLOOK THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2015 |
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Direttore/Membro del Consiglio | - |
Formazione di John Cini
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
University of North Texas
University of North Texas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
Sonnet BioTherapeutics Holdings, Inc.
Sonnet BioTherapeutics Holdings, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
















